European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading

European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.6% to 1,436.74 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS), which rose 5.3%, followed by electronics company Philips (PHG) and biopharmaceutical company Grifols (GRFS), which increased 2.5% and and 2.3%, respectively. Biotech firm BioNTech (BNTX) was up 1.2%.

The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and furniture maker Natuzzi (NTZ), which lost 1.4% and 1.2% respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and pharmaceutical company Ascendis Pharma (ASND), which dropped 1.1% and 0.9% respectively.

From the UK and Ireland, the gainers were led by mining company BHP Group (BHP) and biotech firm Autolus Therapeutics (AUTL), which increased 3.5% and 2.7% respectively. They were followed by biopharmaceutical company Verona Pharma (VRNA) and communications company WPP (WPP), which were up 3.1% and 1.9% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Biodexa Pharmaceuticals (BDRX), which were down 2.4% and 3.2% respectively. They were followed by cruise line operator Carnival (CUK) and biopharmaceutical company Bicycle Therapeutics (BCYC), which were off 0.6% and 0.8% respectively.